Note 6 - Inventory
|3 Months Ended|
Mar. 31, 2021
|Notes to Financial Statements|
|Inventory Disclosure [Text Block]||
The components of inventory as of
March 31, 2021and
December 31, 2020are as follows:
three-month period ended
March 31, 2021,we allocated
$4,000of finished goods inventory for use in clinical trials. This transaction was recorded in research and development expense in the consolidated statements of operations.
The entire disclosure for inventory. Includes, but is not limited to, the basis of stating inventory, the method of determining inventory cost, the classes of inventory, and the nature of the cost elements included in inventory.
Reference 1: http://www.xbrl.org/2003/role/disclosureRef